Key takeaways
Methyltestosterone (Methitest) and Aveed (testosterone undecanoate) are both testosterone replacement therapies, but they have some key differences. Methyltestosterone is taken orally and is available in a generic form, while Aveed is an injectable medication that must be administered by a healthcare professional. Methyltestosterone is used to treat low testosterone in males, delayed puberty in males, and breast cancer in females, whereas Aveed is only used to treat low testosterone in adult males. Methyltestosterone can cause serious liver damage with long-term use, while Aveed has a high risk of causing serious lung problems and severe allergic reactions, requiring it to be administered under a drug safety program called Risk Evaluation and Mitigation Strategies (REMS). Additionally, Aveed is only available as a brand medication, which might make it more expensive compared to the generic form of methyltestosterone. Both medications are both categorized as controlled medications, meaning that they have risks of misuse, dependency, and serious side effects.
